Free Trial
NYSE:ARDT

Ardent Health (ARDT) Stock Price, News & Analysis

Ardent Health logo
$13.44 +0.22 (+1.66%)
Closing price 03:59 PM Eastern
Extended Trading
$13.45 +0.01 (+0.07%)
As of 06:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Ardent Health Stock (NYSE:ARDT)

Advanced

Key Stats

Today's Range
$13.03
$13.47
50-Day Range
$10.21
$13.50
52-Week Range
$10.10
$20.72
Volume
274,674 shs
Average Volume
374,556 shs
Market Capitalization
$1.92 billion
P/E Ratio
7.43
Dividend Yield
N/A
Price Target
$19.33
Consensus Rating
Moderate Buy

Company Overview

Ardent Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

ARDT MarketRank™: 

Ardent Health scored higher than 68% of companies evaluated by MarketBeat, and ranked 311th out of 951 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ardent Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 9 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Ardent Health has a consensus price target of $19.33, representing about 43.8% upside from its current price of $13.44.

  • Amount of Analyst Coverage

    Ardent Health has only been the subject of 4 research reports in the past 90 days.

  • Read more about Ardent Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Ardent Health are expected to grow by 59.35% in the coming year, from $1.23 to $1.96 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ardent Health is 7.43, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 281.41.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ardent Health is 7.43, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.29.

  • Price to Earnings Growth Ratio

    Ardent Health has a PEG Ratio of 5.84. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Ardent Health has a P/B Ratio of 1.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Ardent Health's valuation and earnings.
  • Percentage of Shares Shorted

    6.70% of the float of Ardent Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Ardent Health has a short interest ratio ("days to cover") of 5.6.
  • Change versus previous month

  • Dividend Yield

    Ardent Health does not currently pay a dividend.

  • Dividend Growth

    Ardent Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.70% of the float of Ardent Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Ardent Health has a short interest ratio ("days to cover") of 5.6.
  • Change versus previous month

  • News Sentiment

    Ardent Health has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Ardent Health this week, compared to 4 articles on an average week.
  • Search Interest

    Only 2 people have searched for ARDT on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Ardent Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
Receive ARDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ardent Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARDT Stock News Headlines

IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
Ardent Health (NYSE:ARDT) vs. Teladoc Health (NYSE:TDOC) Financial Analysis
Ardent Health initiated with a Buy at UBS
See More Headlines

ARDT Stock Analysis - Frequently Asked Questions

Ardent Health's stock was trading at $17.08 at the start of the year. Since then, ARDT shares have decreased by 21.3% and is now trading at $13.44.

Ardent Health, Inc. (NYSE:ARDT) announced its quarterly earnings results on Tuesday, August, 5th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.30 by $0.22. The company earned $1.65 billion during the quarter, compared to analysts' expectations of $1.54 billion. Ardent Health had a net margin of 4.11% and a trailing twelve-month return on equity of 16.66%.
Read the conference call transcript
.

Ardent Health (ARDT) raised $192 million in an IPO on Thursday, July 18th 2024. The company issued 12,000,000 shares at $16.00 per share.

Top institutional shareholders of Ardent Health include Ameriprise Financial Inc. (1.14%), Goldentree Asset Management LP (0.81%), Allspring Global Investments Holdings LLC (0.58%) and SageView Advisory Group LLC (0.55%).

Shares of ARDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ardent Health investors own include Broadcom (AVGO), 4D Molecular Therapeutics (FDMT), Mirum Pharmaceuticals (MIRM), Micron Technology (MU), Uber Technologies (UBER), Advanced Micro Devices (AMD) and ASML (ASML).

Company Calendar

Last Earnings
8/05/2025
Today
9/24/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NYSE:ARDT
Previous Symbol
NYSE:ARDT
CIK
1756655
Web
N/A
Fax
N/A
Employees
24,900
Year Founded
N/A

Price Target and Rating

High Price Target
$25.00
Low Price Target
$14.60
Potential Upside/Downside
+47.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.81
Trailing P/E Ratio
7.24
Forward P/E Ratio
10.64
P/E Growth
5.76
Net Income
$210.34 million
Net Margins
4.11%
Pretax Margin
6.78%
Return on Equity
16.66%
Return on Assets
5.18%

Debt

Debt-to-Equity Ratio
0.66
Current Ratio
2.13
Quick Ratio
2.00

Sales & Book Value

Annual Sales
$5.97 billion
Price / Sales
0.31
Cash Flow
$2.55 per share
Price / Cash Flow
5.14
Book Value
$10.66 per share
Price / Book
1.23

Miscellaneous

Outstanding Shares
143,110,000
Free Float
140,673,000
Market Cap
$1.87 billion
Optionable
Optionable
Beta
0.30

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSE:ARDT) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners